Koss's Cytology of the Urinary Tract with Histopathologic Correlations (eBook)

FCRP Leopold G. Koss MD, FIAC Rana S. Hoda MD (Autoren)

eBook Download: PDF

2012 | 2012
XVI, 125 Seiten
Springer New York (Verlag)
978-1-4614-2056-9 (ISBN)

Infos

This new volume fills the gap in the literature as it will guide urologists and pathologists in the proper utilization of a variety of laboratory methods that are currently available to determine the presence, persistence or progression of tumors of the lower urinary tract. The volume emphasizes cytology of the urinary tract which is preferred over other methods (i.e. biochemical, immunological and cytogenetic) for its accuracy, especially for the important high grade tumors. This volume will appeal to urologists as well as pathologists, cytopathologists and related professions. The illustrations, nearly all in color, stress the key points of the text and enhance basic understanding of urothelial and other tumors of the urinary tract.

Inhalt

Chapter 1- IntroductionChapter 2- Indication, Collection and Laboratory Processing of Cytologic SamplesPrincipal IndicationCollection TechniquesLaboratory Processing of SamplesSuggested ReadingChapter 3- The Cellular and Acellular Components of the Urinary SedimentNormal Urothelium (Transitional Epithelium) and Its CellsOther Benign CellsNoncellular Components of the Urinary SedimentSuggested Reading Chapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection TechniqueVoided urineCytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by BrushingCytologic Makeup of Ileal Bladder UrineChapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of theLower Urinary TractInflammatory disorders Cellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesChapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection TechniqueVoided urineCytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by BrushingCytologic Makeup of Ileal Bladder UrineChapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of theLower Urinary TractInflammatory disorders Cellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesCellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesChapter 4- The Cytologic Makeup of the Urinary Sediment According to the Collection TechniqueVoided urineCytologic Makeup of Bladder Washings Cytologic Makeup of Normal Specimens Obtained by Retrograde Catheterization Cytologic Makeup of Smears Obtained by BrushingCytologic Makeup of Ileal Bladder UrineChapter 5- Cytologic Manifestations of Benign Disorders Affecting Cells of theLower Urinary TractInflammatory disorders Cellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesCellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferencesCellular inclusions not due to viral agentsTrematodes and other parasitesLithiasisLeukoplakiaEffect of DrugsEffects of radiotherapyMonitoring of renal transplant patientsUrinary Cytology in Renal Transplant PatientsRare benign conditionsSuggested ReadingChapter 6- Tumors of the BladderNon-Neoplastic ChangesHyperplasiaInverted papillomaUrothelial (Transitional) Cell Tumors EpidemiologyClassification and natural historyTypes of Urothelial TumorsA. Papillary Urothelial NeoplasmsI. Tumors with No/Minimal Nuclear Atypia Papilloma, PUNLMP, low grade Papillary Urothelial Carcinoma II. High-Grade Papillary Urothelial CarcinomaB. Nonpapillary Urothelial TumorsI. Invasive Urothelial CarcinomasII. Flat Carcinoma In Situ (IUN III): Clinical Presentation, HistologyHistologic Variants of Urothelial CarcinomaMetastatic Tumors Cytologic Monitoring of Patients Treated for Tumors of Lower Urinary TractReporting of cytologic findingsSuggested ReadingChapter 7- Immunohistochemistry, Immunocytochemistry and Other Methods of Detection of Bladder NeoplasmsIntroductionUS FDA-approved MarkersPotential Markers in Earlier Phases of Clinical DevelopmentMarkers Detected by ImmunocytochemistryComparison between Urine Cytology and FDA-approved MarkersConclusionReferences

Produkt-Details

• Erscheint lt. Verlag: 11.2.2012
• Zusatzinfo: XVI, 125 p. 81 illus., 71 illus. in color.
• Verlagsort: New York
• Sprache: englisch
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie
• Themenwelt: Studium ► 2. Studienabschnitt (Klinik) ► Pathologie
• ISBN-10: 1-4614-2056-3 / 1461420563
• ISBN-13: 978-1-4614-2056-9 / 9781461420569